Personen

Ärztlicher / Beruflicher Werdegang

seit 2020

Consultant Pathologist for Thoracic Surgical Pathology, Institute of Pathology

seit 2019

Board Certification in Pathology

Wissenschaftlicher Werdegang

seit 2020

Postdoctoral Lecture Qualification (Habilitation)

seit 2018

Research group leader

seit 2016

MD-Thesis, Institute of Immunology, University of Leipzig

2006 – 2013

Study of Medicine, University of Leipzig and TU Dresden

Auszeichnungen

seit 2018

Hochgesand Award for Pathology

seit 2018

Gerok Fellowship

seit 2014

Post-Doc Fellowship Medical Faculty University Heidelberg                  

Mitgliedschaften

seit 2018

 Member European Society for Pathology

seit 2016

Member German Society for Pathology

10 SELECTED PUBLICATIONS OF THE LAST 2 YEARS

  1. Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes. Kriegsmann M, Zgorzelski C, Casadonte R, Schwamborn K, Muley T, Winter H, Eichhorn M, Eichhorn F, Warth A, Deininger SO, Christopoulos P, Thomas M, Longerich T, Stenzinger A, Weichert W, Müller-Tidow C, Kriegsmann J, Schirmacher P, Kriegsmann K. Cancers (Basel). 2020 Sep 21;12(9):2704. doi: 10.3390/cancers12092704.
  2. Identification of Gastritis Subtypes by Convolutional Neuronal Networks on Histological Images of Antrum and Corpus Biopsies. Steinbuss G, Kriegsmann K, Kriegsmann M. Int J Mol Sci. 2020 Sep 11;21(18):6652. doi: 10.3390/ijms21186652.
  3. Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy. Kriegsmann M, Casadonte R, Maurer N, Stoehr C, Erlmeier F, Moch H, Junker K, Zgorzelski C, Weichert W, Schwamborn K, Deininger SO, Gaida M, Mechtersheimer G, Stenzinger A, Schirmacher P, Hartmann A, Kriegsmann J, Kriegsmann K. J Cancer. 2020 Aug 21;11(20):6081-6089. doi: 10.7150/jca.47698. eCollection 2020.
  4. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry. Wandernoth P, Kriegsmann K, Groh-Mohanu C, Daeumer M, Gohl P, Harzer O, Kriegsmann M, Kriegsmann J. Viruses. 2020 Aug 4;12(8):849. doi: 10.3390/v12080849.
  5. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. Jiang H, Torphy RJ, Steiger K, Hongo H, Ritchie AJ, Kriegsmann M, Horst D, Umetsu SE, Joseph NM, McGregor K, Pishvaian MJ, Blais EM, Lu B, Li M, Hollingsworth M, Stashko C, Volmar K, Yeh JJ, Weaver VM, Wang ZJ, Tempero MA, Weichert W, Collisson EA. J Clin Invest. 2020 Sep 1;130(9):4704-4709. doi: 10.1172/JCI136760.
  6. Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA-binding protein 3 in non-small-cell lung cancer. Kriegsmann K, Zgorzelski C, Muley T, Christopoulos P, von Winterfeld M, Herpel E, Goeppert B, Mechtersheimer G, Sinn P, Stenzinger A, Schirmacher P, Winter H, Eichinger M, Warth A, Kriegsmann M. Histopathology. 2020 Jul 7. doi: 10.1111/his.14203. Online ahead of print.
  7. Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer. Kriegsmann M, Haag C, Weis CA, Steinbuss G, Warth A, Zgorzelski C, Muley T, Winter H, Eichhorn ME, Eichhorn F, Kriegsmann J, Christopoulos P, Thomas M, Witzens-Harig M, Sinn P, von Winterfeld M, Heussel CP, Herth FJF, Klauschen F, Stenzinger A, Kriegsmann K. Cancers (Basel). 2020 Jun 17;12(6):1604. doi: 10.3390/cancers12061604.
  8. Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts. Kazdal D, Endris V, Allgäuer M, Kriegsmann M, Leichsenring J, Volckmar AL, Harms A, Kirchner M, Kriegsmann K, Neumann O, Brandt R, Talla SB, Rempel E, Ploeger C, von Winterfeld M, Christopoulos P, Merino DM, Stewart M, Allen J, Bischoff H, Meister M, Muley T, Herth F, Penzel R, Warth A, Winter H, Fröhling S, Peters S, Swanton C, Thomas M, Schirmacher P, Budczies J, Stenzinger A. J Thorac Oncol. 2019 Nov;14(11):1935-1947. doi: 10.1016/j.jtho.2019.07.006. Epub 2019 Jul 23.
  9. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. Rosenbaum M, Gewies A, Pechloff K, Heuser C, Engleitner T, Gehring T, Hartjes L, Krebs S, Krappmann D, Kriegsmann M, Weichert W, Rad R, Kurts C, Ruland J. Nat Commun. 2019 May 28;10(1):2352. doi: 10.1038/s41467-019-10203-2.
  10. RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours. Longerich T, Endris V, Neumann O, Rempel E, Kirchner M, Abadi Z, Uhrig S, Kriegsmann M, Weiss KH, Breuhahn K, Mehrabi A, Weber TF, Wilkens L, Straub BK, Rosenwald A, Schulze F, Brors B, Froehling S, Pellegrino R, Budczies J, Schirmacher P, Stenzinger A. Gut. 2019 Jul;68(7):1287-1296. doi: 10.1136/gutjnl-2018-317632. Epub 2019 Feb 2.